$BSPK
Bespoke Extracts, Inc.

2024 Q1 Form 10-Q Financial Statement

#000121390024003727 Filed on January 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q3 2022 Q3
Revenue $260.4K $244.4K $0.00
YoY Change 192.56% -100.0%
Cost Of Revenue $157.8K $146.0K $65.00
YoY Change 100.65% 224515.38% -98.98%
Gross Profit $102.6K $98.41K -$65.00
YoY Change 891.22% -151496.92% -100.87%
Gross Profit Margin 39.39% 40.26%
Selling, General & Admin $347.9K $347.7K $1.069M
YoY Change -7.12% -67.49% 542.6%
% of Gross Profit 339.11% 353.34%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.450K $7.180K $0.00
YoY Change 93.28% -100.0%
% of Gross Profit 3.36% 7.3%
Operating Expenses $405.4K $394.6K $1.135M
YoY Change -10.65% -65.22% 578.37%
Operating Profit -$302.8K -$296.2K -$1.135M
YoY Change -31.7% -73.89% 610.31%
Interest Expense -$11.32K $5.337K
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.102K -$5.337K $447.00
YoY Change 12.8% -1293.96%
Pretax Income -$314.1K -$301.5K -$1.134M
YoY Change -28.71% -73.41% 610.03%
Income Tax
% Of Pretax Income
Net Earnings -$314.1K -$301.5K -$1.134M
YoY Change -28.71% -73.41% 610.03%
Net Earnings / Revenue -120.62% -123.37%
Basic Earnings Per Share -$0.03 -$0.03 $0.00
Diluted Earnings Per Share -$0.03 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 10.17M shares 10.17M shares 450.1M shares
Diluted Shares Outstanding 10.17M shares 10.17M shares 375.9M shares

Balance Sheet

Concept 2024 Q1 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.42K $0.00 $10.86K
YoY Change -100.0% -2.86%
Cash & Equivalents $14.42K $10.86K
Short-Term Investments
Other Short-Term Assets $7.350K $25.46K $22.49K
YoY Change -90.81% 13.21% -7.56%
Inventory $38.88K $25.56K $0.00
Prepaid Expenses $1.250K $10.70K $10.49K
Receivables $43.13K $45.95K $20.68K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $103.8K $96.96K $54.02K
YoY Change -30.25% 79.49% -39.32%
LONG-TERM ASSETS
Property, Plant & Equipment $37.53K $42.76K $9.947K
YoY Change -22.08% 329.92% 261.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.00K $12.00K $13.42K
YoY Change 20.0% -10.58%
Total Long-Term Assets $252.1K $291.1K $315.6K
YoY Change -23.55% -7.75% 789.3%
TOTAL ASSETS
Total Short-Term Assets $103.8K $96.96K $54.02K
Total Long-Term Assets $252.1K $291.1K $315.6K
Total Assets $355.8K $388.1K $369.6K
YoY Change -25.64% 5.0% 196.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.137M $828.1K $219.8K
YoY Change 132.1% 276.67% 420.58%
Accrued Expenses $64.33K $64.33K $64.33K
YoY Change 7.22% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $58.37K $27.00K $160.0K
YoY Change -91.54% -83.13% -68.03%
Long-Term Debt Due $85.31K
YoY Change
Total Short-Term Liabilities $1.345M $925.3K $519.2K
YoY Change 7.72% 78.22% -4.35%
LONG-TERM LIABILITIES
Long-Term Debt $849.5K $849.5K $0.00
YoY Change
Other Long-Term Liabilities $133.7K $167.1K $231.4K
YoY Change -33.18% -27.8%
Total Long-Term Liabilities $983.2K $1.017M $231.4K
YoY Change 391.58% 339.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.345M $925.3K $519.2K
Total Long-Term Liabilities $983.2K $1.017M $231.4K
Total Liabilities $2.328M $1.942M $750.6K
YoY Change 60.72% 158.71% 38.29%
SHAREHOLDERS EQUITY
Retained Earnings -$25.68M -$25.10M -$22.89M
YoY Change 5.58% 9.66%
Common Stock $10.17K $10.17K $380.1K
YoY Change 0.0% -97.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.973M -$1.554M -$381.0K
YoY Change
Total Liabilities & Shareholders Equity $355.8K $388.1K $369.6K
YoY Change -25.64% 5.0% 196.85%

Cashflow Statement

Concept 2024 Q1 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$314.1K -$301.5K -$1.134M
YoY Change -28.71% -73.41% 610.03%
Depreciation, Depletion And Amortization $3.450K $7.180K $0.00
YoY Change 93.28% -100.0%
Cash From Operating Activities -$97.19K $4.570K -$174.2K
YoY Change -53.06% -102.62% 142.03%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $470.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $470.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $105.0K -9.000K 160.0K
YoY Change -43.85% -105.63%
NET CHANGE
Cash From Operating Activities -$97.19K 4.570K -174.2K
Cash From Investing Activities 0.000 470.0
Cash From Financing Activities $105.0K -9.000K 160.0K
Net Change In Cash $7.809K -4.430K -13.72K
YoY Change -138.91% -67.71% -80.94%
FREE CASH FLOW
Cash From Operating Activities -$97.19K $4.570K -$174.2K
Capital Expenditures $0.00 $0.00
Free Cash Flow $4.570K -$174.2K
YoY Change -102.62% 142.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52759
dei Entity Registrant Name
EntityRegistrantName
BESPOKE EXTRACTS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4743354
dei Entity Address Address Line1
EntityAddressAddressLine1
12001 E. 33rd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Unit O
dei Entity Address City Or Town
EntityAddressCityOrTown
Aurora
dei Entity Address Country
EntityAddressCountry
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80010
dei Local Phone Number
LocalPhoneNumber
855-633-3738
dei City Area Code
CityAreaCode
855
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10168220 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24433 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45950 usd
CY2023Q3 bspk Prepaid Stock Awards
PrepaidStockAwards
14762 usd
CY2022Q4 bspk Prepaid Stock Awards
PrepaidStockAwards
80113 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10695 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7186 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
25557 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
96964 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
111732 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
42764 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9947 usd
CY2023Q3 bspk License
License
10000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
226381 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
275912 usd
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
12000 usd
CY2023Q3 us-gaap Assets
Assets
388109 usd
CY2022Q4 us-gaap Assets
Assets
409591 usd
CY2023Q3 us-gaap Bank Overdrafts
BankOverdrafts
2949 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
828069 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
295818 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
90000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2936 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
26997 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
415500 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64330 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64330 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
925281 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
865648 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
849500 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
167101 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
216039 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1941882 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1081687 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10168220 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10168220 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9946067 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9946067 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
10166 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9944 usd
CY2023Q3 bspk Common Stock Shares Issuance
CommonStockSharesIssuance
6478 shares
CY2022Q4 bspk Common Stock Shares Issuance
CommonStockSharesIssuance
6478 shares
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23533615 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23201758 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25097554 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23883798 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1553773 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-672096 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
388109 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409591 usd
CY2023Q3 us-gaap Revenues
Revenues
244408 usd
us-gaap Revenues
Revenues
521671 usd
us-gaap Revenues
Revenues
3407 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
146000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
65 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
341878 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
47580 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
98408 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-65 usd
us-gaap Gross Profit
GrossProfit
179793 usd
us-gaap Gross Profit
GrossProfit
-44173 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
347717 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1069487 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1179598 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2861938 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
46883 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
29270 usd
us-gaap Professional Fees
ProfessionalFees
171259 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1989961 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
4792 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1646030 usd
us-gaap Professional Fees
ProfessionalFees
119118 usd
CY2022Q3 bspk Consulting Fees
ConsultingFees
35750 usd
bspk Consulting Fees
ConsultingFees
36000 usd
bspk Consulting Fees
ConsultingFees
94250 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
394600 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1134507 usd
us-gaap Operating Expenses
OperatingExpenses
1386857 usd
us-gaap Operating Expenses
OperatingExpenses
3075306 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-296192 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1134572 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1207064 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3119479 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
5337 usd
us-gaap Interest Expense
InterestExpense
6692 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
447 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
878 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5337 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
447 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6692 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
878 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-301529 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1134125 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1213756 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3118601 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301529 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1134125 usd
us-gaap Net Income Loss
NetIncomeLoss
-1213756 usd
us-gaap Net Income Loss
NetIncomeLoss
-3118601 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10168220 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8353245 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10165778 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7724148 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1830074 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
170682 usd
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
683087 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1134125 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1549718 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1349547 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
97303 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-301529 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1553773 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
683086 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
344450 usd
us-gaap Net Income Loss
NetIncomeLoss
-3118601 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1549718 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-672096 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
50000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
282079 usd
us-gaap Net Income Loss
NetIncomeLoss
-1213756 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1553773 usd
us-gaap Net Income Loss
NetIncomeLoss
-1213756 usd
us-gaap Net Income Loss
NetIncomeLoss
-3118601 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
40393 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
46825 usd
us-gaap Depreciation
Depreciation
7183 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3636 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
49531 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
65351 usd
us-gaap Share Based Compensation
ShareBasedCompensation
282079 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2329116 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45950 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3509 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4047 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
65950 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
431 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
1416 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
535200 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
141113 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2936 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-48938 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-855 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-395430 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-604660 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
12000 usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
20250 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7202 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39452 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
4791 usd
bspk Payment Of Inventory Earnout
PaymentOfInventoryEarnout
90000 usd
bspk Proceeds From Issuance Of Note Payable Related Party
ProceedsFromIssuanceOfNotePayableRelatedParty
434000 usd
bspk Proceeds From Issuance Of Note Payable Related Party
ProceedsFromIssuanceOfNotePayableRelatedParty
160000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
26997 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2500 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
344450 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
370997 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
506741 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24433 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137371 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24433 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148227 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10856 usd
us-gaap Stock Issued1
StockIssued1
50000 usd
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
222223 shares
CY2023Q1 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
bspk Negative Cash Flows From Operations
NegativeCashFlowsFromOperations
395430 usd
bspk Working Capital Deficit
WorkingCapitalDeficit
851602 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25097554 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and accompanying notes. Significant estimates include the assumption used in the valuation of equity-based transactions, valuation of intangible assets, allowance for doubtful accounts and inventory valuation and reserves. Actual results could differ from those estimates. </p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
25557 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
0 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
25557 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022 bspk Total Accounts Receivable
TotalAccountsReceivable
0.10 pure
bspk Number Of Customer
NumberOfCustomer
1 pure
bspk Sales Percentage
SalesPercentage
0.333 pure
CY2022Q3 bspk Total Sales
TotalSales
0.10 pure
bspk Total Sales
TotalSales
0.10 pure
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Revenue</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred Revenue represents serviced that was paid for but not delivered to the customer as of September 30, 2023.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassification</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior gross prepaid stock compensation and additional paid in capital presented in the 10Q for the period end September 30, 2022 have been reclassified to conform with the financials filed in the December 31, 2022 10K.</p>
CY2023Q3 bspk Shares Warrants
SharesWarrants
1023341 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
562.967 shares
CY2022Q3 bspk Shares Warrants
SharesWarrants
1023842 shares
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
222223 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
CY2023Q3 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
50000 usd
CY2023Q3 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
222223 shares
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
50000 usd
us-gaap Taxes And Licenses
TaxesAndLicenses
10000 usd
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
40000 usd
CY2022Q3 bspk Operating Profit Sale Percentage
OperatingProfitSalePercentage
0.40 pure
CY2022Q3 us-gaap Inventory Gross
InventoryGross
75000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
90000 usd
CY2022Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10000 usd
CY2022Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
25000 usd
CY2022 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
931 usd
CY2022 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
45931 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49947 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9947 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7183 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42764 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9947 usd
CY2023Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2617 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7183 usd
CY2022Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
0 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
0 usd
CY2023Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
434000 usd
CY2023Q3 us-gaap Other Notes Payable
OtherNotesPayable
849500 usd
CY2023Q3 us-gaap Percentage Of Interest Bearing Domestic Deposits To Deposits
PercentageOfInterestBearingDomesticDepositsToDeposits
0.05 pure
CY2023Q3 us-gaap Receivable With Imputed Interest Due Dates
ReceivableWithImputedInterestDueDates
2025-06-30
CY2023Q3 bspk Net Proceeds
NetProceeds
2000000 usd
CY2023Q3 bspk Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
885454 usd
CY2022Q4 bspk Note Payable Related Parties Classified Current
NotePayableRelatedPartiesClassifiedCurrent
415500 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
26997 usd
CY2023Q3 us-gaap Lessee Finance Lease Remaining Lease Term
LesseeFinanceLeaseRemainingLeaseTerm
P5Y
CY2023Q3 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
us-gaap Payments For Rent
PaymentsForRent
6000 usd
CY2023Q3 us-gaap Purchase Obligation
PurchaseObligation
600000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M8D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04 pure
us-gaap Operating Lease Cost
OperatingLeaseCost
57294 usd
us-gaap Lease Cost
LeaseCost
60444 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
16641 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
75915 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
79380 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
72765 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
244701 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
13270 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
231431 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
222223 shares
CY2023Q1 us-gaap Supplemental Deferred Purchase Price
SupplementalDeferredPurchasePrice
50000 usd
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.225
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
675000 usd
CY2022 bspk Shares Issued To Investors
SharesIssuedToInvestors
1530897 shares
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1530897 shares
CY2022 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
344450 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2023-06-30
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
2.25
CY2022Q3 bspk Shares Of Common Stock
SharesOfCommonStock
266667 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
155556 shares
CY2022 us-gaap Other Expenses
OtherExpenses
1104928 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
21544 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
43328 usd
us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
38785 usd
CY2022 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
80113 usd
bspk Shares Issued To Investors
SharesIssuedToInvestors
50000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
12500000 shares
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
250000 usd
us-gaap Legal Fees
LegalFees
10000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
2.25
CY2023Q3 us-gaap Percentage Of Interest Bearing Domestic Deposits To Deposits
PercentageOfInterestBearingDomesticDepositsToDeposits
0.05 pure
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
2000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
30811 usd
us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
92433 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
67797 usd
us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
203391 usd
us-gaap Fair Value Option Credit Risk Gains Losses On Assets
FairValueOptionCreditRiskGainsLossesOnAssets
900000 usd
CY2021Q4 us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
22222 shares
CY2021Q4 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1.35
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
30000 usd
CY2023Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
24900 usd
CY2023Q3 us-gaap Option Indexed To Issuers Equity Shares
OptionIndexedToIssuersEquityShares
222500 shares
CY2023Q3 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
0.2
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
44306 usd
us-gaap Present Value Of Future Insurance Profits Amortization Expense1
PresentValueOfFutureInsuranceProfitsAmortizationExpense1
271054 usd
bspk Advance Amount
AdvanceAmount
434000 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
849500 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
415500 usd
CY2023Q3 us-gaap Other Notes Payable
OtherNotesPayable
849500 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
26997 usd
CY2023Q3 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
165000 usd
CY2023Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
138066 usd
CY2021Q3 bspk Principal Amounts
PrincipalAmounts
400000 usd
CY2022Q3 bspk Operating Profit Percentage
OperatingProfitPercentage
0.40 pure
CY2022Q4 us-gaap Progress Payments Netted Against Inventory For Long Term Contracts Or Programs
ProgressPaymentsNettedAgainstInventoryForLongTermContractsOrPrograms
90000 usd
CY2021Q4 bspk Executive Officer Salary
ExecutiveOfficerSalary
8000 usd
CY2021Q4 bspk Stock Issued During Period Shares Others
StockIssuedDuringPeriodSharesOthers
666667 shares
CY2021Q4 us-gaap Stock Option Exercise Price Decrease
StockOptionExercisePriceDecrease
0.06
CY2021Q4 bspk Premium Percentage
PremiumPercentage
1.20 pure
CY2023Q3 bspk Additional Loan Amount
AdditionalLoanAmount
33000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
usd
CY2022Q4 bspk License
License
usd
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 bspk Common Stock Value Issue
CommonStockValueIssue
usd
CY2022Q4 bspk Common Stock Value Issue
CommonStockValueIssue
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 bspk Consulting Fees
ConsultingFees
usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
usd
us-gaap Interest Expense
InterestExpense
usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
usd
us-gaap Interest And Other Income
InterestAndOtherIncome
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10168152 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10168152 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7724148 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8353244 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
bspk Payment Of Inventory Earnout
PaymentOfInventoryEarnout
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001409197

Files In Submission

Name View Source Status
0001213900-24-003727-index-headers.html Edgar Link pending
0001213900-24-003727-index.html Edgar Link pending
0001213900-24-003727.txt Edgar Link pending
0001213900-24-003727-xbrl.zip Edgar Link pending
bspk-20230930.xsd Edgar Link pending
f10q0923ex31-1_bespoke.htm Edgar Link pending
f10q0923ex32-1_bespoke.htm Edgar Link pending
f10q0923_bespokeextracts.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0923_bespokeextracts_htm.xml Edgar Link completed
bspk-20230930_def.xml Edgar Link unprocessable
bspk-20230930_cal.xml Edgar Link unprocessable
bspk-20230930_pre.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bspk-20230930_lab.xml Edgar Link unprocessable